Moreover, the Sbds deletion observed in osterix+ MDS-MSCs promotes genotoxic stress in HSPCs through inflammatory p53-S100A8/9-TLR signalling, leading to MDS progression [42]. The gene discussed is TP53; the disease is myelodysplastic syndrome.